Based on the Chemed Corp stock forecast from 1 analysts, the average analyst target price for Chemed Corp is USD 650.00 over the next 12 months. Chemed Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Chemed Corp is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Chemed Corp’s stock price was USD 561.34. Chemed Corp’s stock price has changed by +3.64% over the past week, +6.35% over the past month and -6.76% over the last year.
No recent analyst target price found for Chemed Corp
No recent average analyst rating found for Chemed Corp
Company Overview Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. Read Less
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It of...Read More
Frequently Asked Questions About Chemed Corp (CHE) Stock
Based on ratings from 1 analysts Chemed Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
CHE stock's dividend yield is 0.38%.
Our analysis grades CHE stock's dividend yield at F. This means that CHE stock's dividend yield is above 14% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this CHE may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for CHE is USD 650.00 over the next 12 months. The maximum analyst target price is USD 650 while the minimum anlayst target price is USD 650.
CHE stock's Price/Earning ratio is 26.38.
Our analysis grades CHE stock's Price / Earning ratio at F. This means that CHE stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this CHE may be a overvalued for its sector.
The last closing price of CHE's stock was USD 561.34.
The most recent market capitalization for CHE is USD 7.82B.
Based on targets from 1 analysts, the average taret price for CHE is projected at USD 650.00 over the next 12 months.
This means that CHE's stock price may go up by +15.79% over the next 12 months.
We can't find any ETFs which contains Chemed Corp's stock.
As per our most recent records Chemed Corp has 15,087 Employees.
Chemed Corp's registered address is 255 East Fifth Street, Cincinnati, OH, United States, 45202-4726.
You can get more information about it from Chemed Corp's website at https://www.chemed.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Chemed Corp (CHE) Stock
Based on ratings from 1 analysts Chemed Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
CHE stock's dividend yield is 0.38%.
Our analysis grades CHE stock's dividend yield at F. This means that CHE stock's dividend yield is above 14% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this CHE may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for CHE is USD 650.00 over the next 12 months. The maximum analyst target price is USD 650 while the minimum anlayst target price is USD 650.
CHE stock's Price/Earning ratio is 26.38.
Our analysis grades CHE stock's Price / Earning ratio at F. This means that CHE stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this CHE may be a overvalued for its sector.
The last closing price of CHE's stock was USD 561.34.
The most recent market capitalization for CHE is USD 7.82B.
Based on targets from 1 analysts, the average taret price for CHE is projected at USD 650.00 over the next 12 months.
This means that CHE's stock price may go up by +15.79% over the next 12 months.
We can't find any ETFs which contains Chemed Corp's stock.
As per our most recent records Chemed Corp has 15,087 Employees.
Chemed Corp's registered address is 255 East Fifth Street, Cincinnati, OH, United States, 45202-4726.
You can get more information about it from Chemed Corp's website at https://www.chemed.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CHE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
